Article
Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Medicine - 28 Aug 2020
Ishiguro Kazuya, Sasaki Yasushi, Takagi Yoshitake, Niinuma Takeshi, Suzuki Hiromu, Tokino Takashi, Hayashi Toshiaki, Takahashi Tohru, Igarashi Tetsuyuki, Matsuno Yoshihiro
Abstract excerpt
RATIONALE: Aggressive variant of splenic marginal zone lymphoma (AV-SMZL) is a very rare disease that is often associated with TP53 mutations and has a poor prognosis. On the other hand, recent advances in genome sequencing techniques enable us to understand the molecular characteristics of rare cancers such as AV-SMZL. Here we present a case of AV-SMZL analyzed using a genetic test. PATIENT CONCERNS: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.